Form 8-K - Current report:
SEC Accession No. 0001753926-24-002130
Filing Date
2024-12-20
Accepted
2024-12-20 16:05:18
Documents
13
Period of Report
2024-12-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K g084611_8k.htm   iXBRL 8-K 32366
  Complete submission text file 0001753926-24-002130.txt   207104

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE lipo-20241220.xsd EX-101.SCH 3012
3 XBRL LABEL FILE lipo-20241220_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE lipo-20241220_pre.xml EX-101.PRE 22357
15 EXTRACTED XBRL INSTANCE DOCUMENT g084611_8k_htm.xml XML 3857
Mailing Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208
Business Address 400 N LEXINGTON ST STE LL103 PITTSBURGH PA 15208 412-901-0315
LIPELLA PHARMACEUTICALS INC. (Filer) CIK: 0001347242 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41575 | Film No.: 241567920
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)